Jyong Biotech Profit Margin 1971-1970 | MENS

Current and historical gross margin, operating margin and net profit margin for Jyong Biotech (MENS) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Jyong Biotech net profit margin as of January 01, 1970 is 0%.
Jyong Biotech Annual Profit Margins
Jyong Biotech Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.722B $0.000B
Jyong Biotech Ltd. is a science-driven biotechnology company. It involved in developing and commercializing new drugs mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia. Jyong Biotech Ltd. is based in New Taipei City, Taiwan.
Stock Name Country Market Cap PE Ratio
Caris Life Sciences,�Inc (CAI) $6.821B 0.00
Slide Insurance Holdings (SLDE) United States $2.580B 0.00
Flowco Holdings (FLOC) United States $1.616B 0.00
New Providence Acquisition III (NPAC) $0.394B 0.00
Inflection Point Acquisition III (IPCX) $0.351B 0.00
Aduro Clean Technologies (ADUR) Canada $0.273B 0.00
Oaktree Acquisition III Life Sciences (OACC) United States $0.235B 0.00
Range Capital Acquisition (RANG) United States $0.143B 0.00
Tavia Acquisition (TAVI) $0.142B 0.00
YSX Tech (YSXT) China $0.121B 0.00
Youxin Technology (YAAS) China $0.111B 0.00
CO2 Energy Transition (NOEM) United States $0.096B 0.00
Leishen Energy Holding (LSE) China $0.090B 0.00
ChampionsGate Acquisition (CHPG) $0.087B 0.00
YHN Acquisition I (YHNA) $0.082B 0.00
Uni-Fuels Holdings (UFG) $0.069B 0.00
Happy City Holdings (HCHL) $0.036B 0.00
PicoCELA (PCLA) Japan $0.033B 0.00
New Century Logistics (BVI) (NCEW) Hong Kong, SAR China $0.021B 0.00
Hong Kong Pharma Digital Technology Holdings (HKPD) $0.016B 0.00
Sky Quarry (SKYQ) United States $0.014B 0.00